Respilite Tablet
Marketer
Anthus Pharmaceuticals Pvt Ltd
Salt Composition
Ambroxol (75mg) + Levocetirizine (5mg) + Montelukast (10mg)
Overview Respilite Tablet
BronchoClear tablets combine medications to treat respiratory illnesses involving thick mucus. This provides relief from productive coughs associated with conditions such as asthma, bronchitis, and the common cold. BronchoClear should be taken as directed by your physician, with or without food. Dosage depends on individual response and condition; complete the prescribed course to prevent symptom recurrence and potential worsening. Inform your doctor of all other medications you're using, as interactions are possible. Common side effects include nausea, indigestion, dry mouth, flu-like symptoms, tiredness, and headache; most are temporary. Report any concerning side effects immediately. Drowsiness and dizziness may occur; avoid driving or activities requiring concentration until effects are known. Alcohol should be avoided due to increased drowsiness. Prior to use, disclose any kidney or liver conditions and pregnancy/breastfeeding plans for appropriate dosage adjustment.
Uses of Respilite Tablet
Management of respiratory illnesses characterized by thick mucus.
Major Benefits of Respilite Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Respilite Tablets can be administered with or without food, although consistent timing is recommended.
Common Side effects of Respilite Tablet:
- Nausea
- Upset stomach
- Dryness in mouth
- Headache
- Fatigue
- Allergic reaction
- Sleepiness
- Flu-like symptoms
How to use Respilite Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the tablet whole; do not crush, chew, or divide it. Respilite Tablets can be administered with or without food, however, consistent timing is recommended.
How Respilite Tablet works:
Tri-Med Respiratory Relief tablets unite ambroxol, levocetirizine, and montelukast to address respiratory symptoms. Ambroxol, a mucolytic agent, facilitates mucus expulsion by reducing its viscosity. Levocetirizine, an antihistamine, targets allergic reactions, alleviating symptoms such as nasal discharge, ocular itching, and sneezing. Montelukast, a leukotriene receptor antagonist, inhibits leukotriene activity, thereby lessening airway and nasal inflammation and improving overall symptom control.
SAFETY ADVICE
AlcoholCAUTION
Use of Respilite Tablet with alcohol requires careful consideration. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Use of Respilite Tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Respilite Tablets while breastfeeding is likely inadvisable. Preliminary research in humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Respilite Tablets might reduce awareness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use Respilite Tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Respilite Tablets are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should use Respilite tablets judiciously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Respilite Tablet :
Should you forget to take a Respilite Tablet, ingest it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Respilite Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Breathing |


